| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.34 | 0.04 |